Expert consensus on the integrated diagnosis of idiopathic multicentric Castleman disease

Santiago Montes-Moreno1, Fina Climent2, Máximo Fraga3

  • 1Servicio de Anatomía Patológica y Laboratorio Hematopatología Traslacional, Hospital Universitario Marqués de Valdecilla/IDIVAL, Centro para la Investigación Biomédica CIBERONC, Santander, Spain.

Insights

Idiopathic multicentric Castleman disease (iMCD) diagnosis is standardized by expert consensus. This guide offers recommendations for integrated diagnosis, including clinical, lab, and imaging studies for histopathological confirmation.

Area of Science:

  • Hematology
  • Pathology
  • Rheumatology

Background:

  • Idiopathic multicentric Castleman disease (iMCD) is a rare systemic condition.
  • Differential diagnosis includes inflammatory, autoimmune, and neoplastic disorders.
  • Lymph node histopathology is crucial for diagnosing Castleman disease.

Purpose of the Study:

  • To standardize the diagnosis of Castleman disease.
  • To provide recommendations for the integrated diagnosis of iMCD.
  • To establish guidelines for sample handling and result interpretation.

Main Methods:

  • A multi-disciplinary consensus document was created by 53 experts from three medical societies (SEMI, SEHH, SEAP).
  • The Delphi method was employed to reach consensus on diagnostic recommendations.
  • Recommendations cover initial clinical, laboratory, and imaging studies.

Main Results:

  • Specific recommendations for integrated iMCD diagnosis were developed.
  • Guidelines for optimal sample acquisition for histopathology were established.
  • Standardized procedures for laboratory testing and result reporting were defined.

Conclusions:

  • Standardized diagnostic criteria and procedures are essential for iMCD.
  • Expert consensus provides a framework for consistent and accurate diagnosis.
  • This consensus aims to improve patient management through reliable diagnosis.

Related Concept Videos